Postes actifs de Omid Karkouti
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Rarebase, PBC
 Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Directeur des opérations | - | - |
| Fondateur | - | - |
Historique de carrière de Omid Karkouti
Anciens postes connus de Omid Karkouti
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Reformer Therapeutics, Inc.
 Reformer Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Reformer Therapeutics, Inc. develops therapy for cancer treatment. | Fondateur | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Services | 2 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Reformer Therapeutics, Inc.
Reformer Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Reformer Therapeutics, Inc. develops therapy for cancer treatment. | Health Services |
Rarebase, PBC
Rarebase, PBC Packaged SoftwareTechnology Services Rarebase, PBC is a biotech company that is dedicated to discovering and developing medicines for rare diseases. The company is based in Palo Alto, CA and was founded by Onno Faber and Omid Karkouti. The company has a product engine that is designed to discover treatments for hundreds of monogenic diseases simultaneously. Rarebase has already uncovered potential treatments for hundreds of rare diseases and has built a "drug-gene atlas" to enable AI-driven drug discovery. Onno Faber has been the CEO since incorporation. | Technology Services |
- Bourse
- Insiders
- Omid Karkouti
- Expérience
